← Back to headlines
Merck & Co. Strengthens Vaccine Portfolio with New Capvaxive Approval
An article discusses whether Merck & Co., Inc. (MRK) is strengthening its vaccine portfolio with the recent approval of its new Capvaxive vaccine.
24 Jun, 13:26 — 24 Jun, 13:26
Sources
Showing 1 of 1 sources
